Medications, substances, and lifestyle factors that quietly kill your testosterone

Opioids, anabolic steroids, heavy alcohol use, obesity, and chronic sleep loss can all lower testosterone. When the drop persists and causes symptoms, it can amount to male hypogonadism. Many medications that lower testosterone do not damage the testes directly. They suppress the brain to testes signaling loop, which means the right treatment depends on LH and FSH, not on testosterone alone.

Key takeaways

• Male hypogonadism is a clinical syndrome that requires both persistent symptoms and biochemical evidence of testosterone deficiency. One low lab value alone is not a diagnosis.
• The Endocrine Society recommends measuring testosterone in the morning while fasting and repeating the test to confirm a low result. Free testosterone is added when total testosterone is borderline or SHBG is altered.
• LH and FSH should be measured with testosterone. High LH with low testosterone points to primary hypogonadism, while low or normal LH with low testosterone points to secondary hypogonadism.
• Opioids lower testosterone because they suppress GnRH, LH, and FSH. Exogenous testosterone and anabolic steroids strongly suppress natural testosterone production through negative feedback and can leave men with secondary hypogonadism, especially after they stop or when their own production is being assessed.
• Obesity is one of the best documented modifiable causes of low testosterone. It is strongly associated with secondary hypogonadism, and weight loss raises testosterone while lowering estradiol.
• Chronic heavy alcohol use and chronic systemic disease can produce mixed hypogonadism. Chemotherapy, especially alkylating agents, more often causes primary hypogonadism through direct testicular damage. Some endocrine disrupting chemicals may also impair testicular function, although individual causation is hard to prove in adults.

When these factors actually count as hypogonadism

Male hypogonadism is a clinical syndrome that requires both persistent symptoms and confirmed biochemical testosterone deficiency on reliable morning testing.^[1]

Biochemical evidence means consistently low testosterone on a properly collected blood test. Symptoms matter just as much. In practice, that usually means sexual symptoms such as low libido, erectile dysfunction, or loss of morning erections, often with fatigue, reduced physical performance, or worsening body composition. For the diagnostic standard itself, see the clinical definition of low testosterone.

According to the Endocrine Society guideline, the first test should be a fasting morning total testosterone measured with an accurate and reliable assay, and a low result should be confirmed with a repeat morning test. When total testosterone is near the lower limit of normal, or when a condition alters sex hormone binding globulin (SHBG), the guideline recommends measuring free testosterone by equilibrium dialysis or estimating it with an accurate formula. Once deficiency is confirmed, it recommends further evaluation to find the cause.^[1] That is where a careful medication, substance, and lifestyle history becomes useful.

LH and FSH are the decisive companion tests because they classify where the problem starts.^[2] The HPG axis is the hormone signaling loop between the hypothalamus, pituitary, and testes. Primary hypogonadism means the testes are failing. Secondary hypogonadism means the brain is not sending enough LH and FSH. High LH with low testosterone points to primary disease. Low or normal LH with low testosterone points to secondary disease. That distinction shapes treatment. When the testes have failed, testosterone replacement is the usual option. When the problem is secondary, removing the cause or using a treatment that stimulates the pituitary may restore natural production. For the full reasoning, see primary vs secondary hypogonadism.

Opioids, exogenous testosterone, and anabolic steroids

Opioids and exogenous androgens both suppress hypothalamic and pituitary signaling to the testes, which makes them well documented causes of acquired secondary hypogonadism.^{[3] [4]}

Opioids and testosterone

A systematic review in Endocrine Reviews found that in humans, opioids generally decrease LH and testosterone, and that opioid use primarily leads to hypogonadism, with decreased libido and erectile dysfunction as consequences in men.^[3] The main site of action is the hypothalamus, where opioids blunt GnRH, the signal that tells the pituitary to release LH and FSH. When that upstream signal is blunted, the testes may be structurally intact but understimulated.

This pattern usually shows up as low or inappropriately normal LH and FSH with low testosterone, not as high LH from testicular failure. If a man on chronic opioids has persistent symptoms and confirmed low testosterone, the problem is usually central suppression rather than permanent testicular damage. Enclomiphene, which blocks estrogen receptors at the hypothalamus and raises GnRH and LH output, is one treatment that has been studied in secondary hypogonadism. In a 2014 randomized phase II trial published in Fertility and Sterility, enclomiphene citrate raised testosterone, LH, and FSH in men with secondary hypogonadism while maintaining sperm concentration, whereas topical testosterone lowered it.^[5] That trial did not study opioid users.

Opioid induced suppression can improve after dose reduction or discontinuation, but recovery is not always immediate. Some men remain symptomatic for months and still need formal evaluation. In men on long term pain treatment, opioids are one of the first exposures to look for before deciding on therapy.

Exogenous testosterone and anabolic steroids

Testosterone taken from outside the body can shut down the body’s own production. Exogenous testosterone and anabolic steroids raise circulating androgen levels, which increases negative feedback to the hypothalamus and pituitary. In a 2005 randomized trial in healthy men published in the Journal of Clinical Endocrinology and Metabolism, 200 mg of testosterone enanthate weekly, given without hCG, suppressed LH and FSH to 5% and 3% of baseline and lowered intratesticular testosterone by 94% within three weeks.^[4]

In the same study, serum testosterone was only about 1.2% of the concentration inside the testes, and that high intratesticular level is thought to be needed for normal sperm production.^[4] A man using anabolic steroids for physique goals and a man stopping prescribed TRT can arrive at the same endpoint. Both may have low LH, low FSH, and low testosterone for months or longer after discontinuation.

This is still secondary hypogonadism, not primary testicular failure, unless later testing shows high LH that suggests the testes can no longer respond. A 2016 case-control study in PLoS One found that former anabolic steroid users had lower testosterone levels and more hypogonadal symptoms years after stopping than healthy control men.^[6] Because enclomiphene stimulates the HPG axis rather than adding more exogenous testosterone, it is sometimes considered for recovery, but it has not been tested in trials of former steroid users.

Other medications that lower testosterone

Several other drug classes affect androgen action or reproductive hormones by reducing conversion to more potent androgens, raising prolactin, blocking steroid synthesis, or directly damaging the testes. Some lower testosterone itself, while others can cause sexual symptoms without causing biochemical testosterone deficiency.

Finasteride and dutasteride

Finasteride and dutasteride block 5 alpha reductase, the enzyme that converts testosterone to dihydrotestosterone, or DHT. DHT is the more potent androgen in some tissues, especially the prostate, skin, and hair follicles. Many young men take finasteride for hair loss without realizing that it can change androgen signaling even when total testosterone is unchanged or only mildly altered.

The immediate clinical problem is not always a low total testosterone value. It is reduced androgen effect, often with sexual side effects such as lower libido, erectile dysfunction, and altered sexual sensation. In a 2012 follow-up study in The Journal of Sexual Medicine, 96% of 54 men who already had persistent sexual side effects after stopping finasteride still had them 9 to 16 months later.^[7] The study enrolled only men with ongoing symptoms, so it cannot show how often this happens, and the broader post finasteride syndrome debate remains unsettled. Symptoms deserve a full workup, not dismissal, and that workup still needs morning testosterone, free testosterone, LH, and FSH.

SSRIs, glucocorticoids, and prolactin raising drugs

SSRIs and other antidepressants can contribute to sexual dysfunction and may also be part of the medication history in men presenting with low testosterone symptoms. Glucocorticoids are among the medications the Endocrine Society guideline lists as causes of low testosterone.^[1] They can act through both central and testicular pathways, so the picture may be secondary, primary, or mixed depending on dose, duration, and the underlying illness.

Hyperprolactinemia inducing drugs deserve special attention. Prolactin is a pituitary hormone that suppresses GnRH when it is elevated in men, so medications that raise prolactin can cause secondary hypogonadism through reduced pituitary signaling. The Endocrine Society guideline recommends measuring prolactin when testosterone is low and LH is low or normal.^[1]

Estrogens and progestogens also suppress the HPG axis. If the brain sees enough estrogenic or progestogenic feedback, LH and FSH fall and natural testosterone production falls with them. This is another setting where low or normal LH with low testosterone points to secondary suppression rather than primary failure.

Chemotherapy and steroid synthesis blockers

Chemotherapy can damage the testes directly. A 2005 review in the Journal of the National Cancer Institute Monographs identified alkylating agents as the drugs most often implicated in gonadal damage in men.^[8] Sperm producing cells are the most sensitive, but the testosterone producing Leydig cells can also be affected. When the testes are damaged, LH often rises because the pituitary is trying harder to stimulate them. That high LH plus low testosterone pattern is why Enclomiphene is not appropriate in chemotherapy related primary hypogonadism. Testes that no longer respond to LH will not respond to more of it.

Ketoconazole and aminoglutethimide lower testosterone by inhibiting steroid synthesis. If a man develops symptoms while taking one of these drugs, the correct response is not to assume idiopathic low testosterone. It is to recognize a specific medication exposure and classify the lab pattern correctly.

Obesity, metabolic syndrome, and type 2 diabetes

Obesity is one of the best documented modifiable causes of low testosterone in men, and it usually produces functional secondary hypogonadism rather than irreversible testicular failure.^{[2] [9]}

Aromatase is the enzyme in adipose tissue that converts testosterone to estradiol, and more body fat means more of this conversion. Estradiol adds negative feedback on the HPG axis, so LH and testosterone fall. Weight loss reverses part of this pattern: it lowers estradiol and raises gonadotropins and testosterone.^[9] Low testosterone in turn favors fat gain, which is why the relationship is often described as two way.

The European Male Ageing Study, a survey of 3,369 men aged 40 to 79, found that a body mass index of 30 or higher was strongly associated with secondary hypogonadism, with a relative risk ratio of 8.74.^[2] Obesity related low testosterone is reversible in principle but not always easy to reverse in practice. A 2013 meta-analysis of 24 studies in the European Journal of Endocrinology found that total testosterone rose by about 2.9 nmol/L after a low calorie diet and about 8.7 nmol/L after bariatric surgery, with larger gains in men who lost more weight.^[9]

Metabolic syndrome adds another layer. Central obesity, hyperglycemia, insulin resistance, dyslipidemia, and hypertension cluster together, and each is linked to lower testosterone. Hypogonadotropic hypogonadism is common in men with type 2 diabetes. In a 2004 study of 103 men with type 2 diabetes in the Journal of Clinical Endocrinology and Metabolism, about a third were hypogonadal, and their LH and FSH were lower than in men with normal testosterone.^[10] Insulin resistance also appears to impair testicular function independently, which means these men can have both central and peripheral pressure on testosterone production.

Erectile dysfunction is common in men with metabolic syndrome or type 2 diabetes, and low testosterone is often one component of that picture. When obesity and low testosterone occur together, the correct label is often functional hypogonadism. That means the axis is suppressed, not destroyed, and treatment should reflect that. For the lab roadmap, see the complete testing guide.

Alcohol, environmental toxins, and chronic disease

Alcohol, endocrine disrupting chemicals, and chronic systemic illness can lower testosterone through mixed mechanisms that involve both central suppression and impaired testicular function.

Alcohol and testosterone

Chronic heavy alcohol use is not just a liver issue. It has direct toxic effects on the testes and also changes hepatic hormone handling, which can alter SHBG and testosterone bioavailability. A 2018 review in Reproductive Biology and Endocrinology noted that negative effects of alcohol on gonadal function have been reported consistently over the past 30 years.^[11] Clinically, alcohol can produce a mixed picture with both primary damage and secondary HPG suppression.

That mixed mechanism is why labs matter. A man with chronic heavy alcohol exposure may show high LH if testicular injury dominates, or low or normal LH if central suppression dominates. The treatment path is not the same in those two scenarios.

Environmental toxins

Environmental endocrine disrupting chemicals, including bisphenol A, phthalates, and some pesticides, can interfere with androgen signaling. According to the Endocrine Society’s second scientific statement on endocrine disrupting chemicals, male reproduction is one of the areas where the evidence is strongest, with exposure during development of particular concern, but causality in humans has to be inferred with caution.^[12] It is much harder to prove that one man’s exposure directly caused his low testosterone, so in most adult cases these exposures are better treated as possible contributors than as a standalone diagnosis.

Chronic disease and acute illness

Chronic systemic diseases can act at both levels of the axis. In the European Male Ageing Study, comorbidity was associated with both secondary and primary hypogonadism.^[2] Relevant conditions include chronic organ failure, Cushing syndrome, HIV, COPD, renal disease, and cancer. In these settings, inflammation, malnutrition, organ dysfunction, and medication burden all converge. The testes may function less well, while hypothalamic and pituitary signaling also weakens.

Acute and critical illness are different. They can temporarily suppress testosterone enough to mimic hypogonadism, but this may be transient functional suppression rather than a chronic disorder. According to the Endocrine Society guideline, hypogonadism should not be diagnosed during acute illness because the result may normalize after recovery.^[1] If a low value was drawn during hospitalization, infection, surgery, or another acute stressor, testing should be repeated after recovery.

Lifestyle causes of low testosterone

Chronic sleep restriction, endurance overtraining, eating disorders, and persistent stress can lower testosterone mainly by suppressing the HPG axis rather than by permanently damaging the testes.

Sleep deprivation

Testosterone production is tightly linked to sleep. In a 2011 study published in JAMA, restricting healthy young men to five hours of sleep a night for one week reduced their daytime testosterone levels by 10% to 15%.^[13] For men with chronic short sleep, rotating shift work, untreated sleep disruption, or repeated late night wakefulness, the endocrine effect can be clinically meaningful.

Chronic stress

Chronic stress raises cortisol, the body’s main stress hormone, and cortisol suppresses hypothalamic GnRH output. If cortisol stays high long enough, LH stimulation to the testes falls and testosterone follows. This is usually secondary hypogonadism, which means the suppression may improve when the stressor is treated, sleep normalizes, and other metabolic strain is reduced.

Endurance overtraining and eating disorders

The Endocrine Society guideline lists excessive exercise and nutritional deficiency, as seen in eating disorders, among causes of acquired secondary hypogonadism.^[1] The common pathway is low energy availability. When calorie intake is chronically inadequate for training load or basic physiologic needs, the brain down regulates reproductive signaling.

These factors are important to identify because they are often reversible. When the testes are intact and LH remains low or normal, correcting the underlying sleep, nutrition, stress, or training problem comes first, and medical treatment can be considered if symptoms and low testosterone persist. If those drivers are ignored, men can be mislabeled as having irreversible low testosterone when the real problem is a suppressive lifestyle exposure.

Myth vs fact

Myth: A single low testosterone result proves you have hypogonadism

Fact: Male hypogonadism requires persistent symptoms plus confirmed biochemical deficiency. Acute illness, poor sleep, stress, and recent substance exposure can all transiently lower testosterone. The Endocrine Society recommends confirming a low fasting morning result with a repeat test before making the diagnosis.^[1]

Myth: Taking testosterone cannot cause low testosterone

Fact: Exogenous testosterone and anabolic steroids suppress LH and FSH through negative feedback, which shuts down natural testosterone production.^[4] That suppression can persist after use stops, and former steroid users have been found to have lower testosterone and more hypogonadal symptoms years later.^[6]

Myth: Hair loss drugs do not affect male hormones

Fact: Finasteride and dutasteride alter androgen metabolism by blocking conversion of testosterone to DHT, without necessarily lowering testosterone itself. Sexual side effects can occur, and whether they persist after discontinuation is an area of active research that should not be dismissed without a proper hormonal workup.^[7]

Myth: Obesity related low testosterone is just about weight

Fact: The relationship between obesity and testosterone is endocrine and metabolic. Excess fat raises estradiol and suppresses LH, and weight loss lowers estradiol while raising gonadotropins and testosterone.^[9] Men with type 2 diabetes commonly have hypogonadism with low or inappropriately normal LH and FSH.^[10]

Myth: Lifestyle change alone reliably fixes functional hypogonadism

Fact: Weight loss, sleep recovery, and removal of offending drugs can improve testosterone, but the gain is often modest. In pooled studies, the average rise in total testosterone after a low calorie diet was about 2.9 nmol/L.^[9] Keeping weight off long term is also difficult, so some men with persistent symptoms and confirmed low testosterone need medical treatment alongside lifestyle change.

Bottom line

Opioids, exogenous androgens, obesity, alcohol, sleep loss, and chronic stress can push men into clinically significant hypogonadism, while finasteride can alter androgen effect and cause sexual symptoms even when testosterone is not low. The next step is confirming persistent symptoms, measuring total and free testosterone in the morning, and checking LH and FSH so the problem is classified correctly before treatment. For the full diagnostic and treatment roadmap, see the Low testosterone hub.

Veedma offers testing that includes total and free testosterone measured by LC-MS/MS with LH and FSH, or a review of labs a man already has, with results interpreted by licensed providers. When appropriate, treatment is enclomiphene or the enclomiphene plus tadalafil tablet. Enclomiphene is not an FDA-approved drug; it is prescribed after a provider confirms the diagnosis and is compounded by a licensed U.S. pharmacy.

References

1. Bhasin S, Brito JP, Cunningham GR, et al. Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2018;103:1715-1744. PMID: 29562364
2. Tajar A, Forti G, O’Neill TW, et al. Characteristics of secondary, primary, and compensated hypogonadism in aging men: evidence from the European Male Ageing Study. J Clin Endocrinol Metab. 2010;95:1810-8. PMID: 20173018
3. Vuong C, Van Uum SH, O’Dell LE, et al. The effects of opioids and opioid analogs on animal and human endocrine systems. Endocr Rev. 2010;31:98-132. PMID: 19903933
4. Coviello AD, Matsumoto AM, Bremner WJ, et al. Low-dose human chorionic gonadotropin maintains intratesticular testosterone in normal men with testosterone-induced gonadotropin suppression. J Clin Endocrinol Metab. 2005;90:2595-602. PMID: 15713727
5. Wiehle RD, Fontenot GK, Wike J, et al. Enclomiphene citrate stimulates testosterone production while preventing oligospermia: a randomized phase II clinical trial comparing topical testosterone. Fertil Steril. 2014;102:720-7. PMID: 25044085
6. Rasmussen JJ, Selmer C, Østergren PB, et al. Former Abusers of Anabolic Androgenic Steroids Exhibit Decreased Testosterone Levels and Hypogonadal Symptoms Years after Cessation: A Case-Control Study. PLoS One. 2016;11:e0161208. PMID: 27532478
7. Irwig MS. Persistent sexual side effects of finasteride: could they be permanent?. J Sex Med. 2012;9:2927-32. PMID: 22789024
8. Howell SJ, Shalet SM. Spermatogenesis after cancer treatment: damage and recovery. J Natl Cancer Inst Monogr. 2005. PMID: 15784814
9. Corona G, Rastrelli G, Monami M, et al. Body weight loss reverts obesity-associated hypogonadotropic hypogonadism: a systematic review and meta-analysis. Eur J Endocrinol. 2013;168:829-43. PMID: 23482592
10. Dhindsa S, Prabhakar S, Sethi M, et al. Frequent occurrence of hypogonadotropic hypogonadism in type 2 diabetes. J Clin Endocrinol Metab. 2004;89:5462-8. PMID: 15531498
11. Sansone A, Di Dato C, de Angelis C, et al. Smoke, alcohol and drug addiction and male fertility. Reprod Biol Endocrinol. 2018;16:3. PMID: 29334961
12. Gore AC, Chappell VA, Fenton SE, et al. EDC-2: The Endocrine Society’s Second Scientific Statement on Endocrine-Disrupting Chemicals. Endocr Rev. 2015;36:E1-E150. PMID: 26544531
13. Leproult R, Van Cauter E. Effect of 1 week of sleep restriction on testosterone levels in young healthy men. JAMA. 2011;305:2173-4. PMID: 21632481